Your Messages Inbox
Your Article Summary
See Latest ArticlesNext-Generation Facilities for Monoclonal Antibody Production
Pharmaceutical Technology, 08/21/09
Guldager N et al. – With hundreds of products in development, and blockbusters already on the market, monoclonal antibodies remain the single most important product group driving the biopharmaceutical industry's development today. The selectivity and flexibility of their mode of action provide the potential for successful therapeutic strategies against medical conditions that, until recently had no effective treatments, let alone a cure.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Article Search
Sponsor